67 related articles for article (PubMed ID: 16829056)
1. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification.
Sorbara MT; Dubin K; Littmann ER; Moody TU; Fontana E; Seok R; Leiner IM; Taur Y; Peled JU; van den Brink MRM; Litvak Y; Bäumler AJ; Chaubard JL; Pickard AJ; Cross JR; Pamer EG
J Exp Med; 2019 Jan; 216(1):84-98. PubMed ID: 30563917
[No Abstract] [Full Text] [Related]
2. Global fluoroquinolone resistance epidemiology and implictions for clinical use.
Dalhoff A
Interdiscip Perspect Infect Dis; 2012; 2012():976273. PubMed ID: 23097666
[TBL] [Abstract][Full Text] [Related]
3. Reply to Chu et al., "Adoption of the New CLSI Fluoroquinolone Breakpoints for
Van TT; Minejima E; Chiu CA; Butler-Wu SM
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31645412
[No Abstract] [Full Text] [Related]
4. The Role of Urinary Nitrite in Predicting Bacterial Resistance in Urine Culture Analysis Among Patients With Uncomplicated Urinary Tract Infection.
Papava V; Didbaridze T; Zaalishvili Z; Gogokhia N; Maziashvili G
Cureus; 2022 Jun; 14(6):e26032. PubMed ID: 35865430
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of
Nakano R; Nakano A; Abe M; Nagano N; Asahara M; Furukawa T; Ono Y; Yano H; Okamoto R
Heliyon; 2019 Mar; 5(3):e01291. PubMed ID: 30886932
[TBL] [Abstract][Full Text] [Related]
6. Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India.
Padmavathy K; Padma K; Rajasekaran S
J Pathog; 2016; 2016():4152704. PubMed ID: 27123344
[TBL] [Abstract][Full Text] [Related]
7. Can urinary nitrite results be used to conduct antimicrobial option for urinary tract infection in children?
Mahyar A; Ayazi P; Froozesh M; Daneshi-Kohan MM; Barikani A
Iran J Pediatr; 2012 Jun; 22(2):237-40. PubMed ID: 23056892
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
Park DW; Peck KR; Chung MH; Lee JS; Park YS; Kim HY; Lee MS; Kim JY; Yeom JS; Kim MJ
J Korean Med Sci; 2012 May; 27(5):476-83. PubMed ID: 22563210
[TBL] [Abstract][Full Text] [Related]
9. Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia.
Matsumura Y; Yamamoto M; Matsushima A; Nagao M; Ito Y; Takakura S; Ichiyama S
Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1931-9. PubMed ID: 22210267
[TBL] [Abstract][Full Text] [Related]
10. Combating antimicrobial resistance: policy recommendations to save lives.
; Spellberg B; Blaser M; Guidos RJ; Boucher HW; Bradley JS; Eisenstein BI; Gerding D; Lynfield R; Reller LB; Rex J; Schwartz D; Septimus E; Tenover FC; Gilbert DN
Clin Infect Dis; 2011 May; 52 Suppl 5(Suppl 5):S397-428. PubMed ID: 21474585
[No Abstract] [Full Text] [Related]
11. Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli Strains clinically isolated from urinary tract infection patients.
Yasufuku T; Shigemura K; Shirakawa T; Matsumoto M; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Kawabata M; Fujisawa M
J Clin Microbiol; 2011 Jan; 49(1):189-94. PubMed ID: 21048014
[TBL] [Abstract][Full Text] [Related]
12. In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
Drago L; Nicola L; Mattina R; De Vecchi E
BMC Microbiol; 2010 Apr; 10():119. PubMed ID: 20409341
[TBL] [Abstract][Full Text] [Related]
13. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
Naber KG; Llorens L; Kaniga K; Kotey P; Hedrich D; Redman R
Antimicrob Agents Chemother; 2009 Sep; 53(9):3782-92. PubMed ID: 19581455
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.
McGregor JC; Allen GP; Bearden DT
Ther Clin Risk Manag; 2008 Oct; 4(5):843-53. PubMed ID: 19209267
[TBL] [Abstract][Full Text] [Related]
15. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.
Muratani T; Matsumoto T
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S10-3. PubMed ID: 16829056
[TBL] [Abstract][Full Text] [Related]
16. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
19. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
